400 mg + 40 mg, suppositories
Tribenoside + Lidocaine
This medicine should always be used exactly as described in the patient leaflet or as directed by a doctor or pharmacist.
Procto-Glyvenol in the form of suppositories is a medicine intended for the local treatment of external and internal hemorrhoids.
Tribenoside has anti-inflammatory, anti-edematous, analgesic, anti-itching effects, and also counteracts vascular endothelial damage.
Lidocaine is a local anesthetic and relieves symptoms caused by hemorrhoids, such as itching, burning, and pain.
Procto-Glyvenol in the form of suppositories acts locally, practically without systemic action.
Before starting to use Procto-Glyvenol in the form of suppositories in people with liver function disorders, this should be discussed with a doctor.
Procto-Glyvenol in the form of suppositories should be used with caution in patients with severe liver damage.
Page 1 of 5
In addition to the treatment of hemorrhoids with Procto-Glyvenol, it is recommended to maintain proper hygiene of the anal area, use appropriate physical exercises, and follow a diet to maintain a soft stool consistency.
This medicine should not be taken orally.
Eye contact should be avoided.
This medicine should not be used in children, as there are no data available on the safety of use in this age group.
No interactions with other medicines have been reported so far.
The patient should tell their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take, including those available without a prescription.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before using this medicine.
Procto-Glyvenol in the form of suppositories should not be used during the first 3 months of pregnancy.
Procto-Glyvenol in the form of suppositories may be used from the 4th month of pregnancy and during breastfeeding, provided that the recommended doses are not exceeded.
Procto-Glyvenol has no influence or negligible influence on the ability to drive and use machines.
This medicine should always be used exactly as described in the patient leaflet or as directed by a doctor or pharmacist. In case of doubt, consult a doctor or pharmacist.
Rectal administration.
The recommended dose is 1 suppository in the morning and 1 suppository in the evening - until the acute symptoms disappear.
Then the dose can be reduced to 1 suppository once a day.
Do not exceed the recommended doses of the medicine.
Wash your hands thoroughly after each use of the medicine.
This medicine should not be used in children, as there are no data available on the safety of use in this age group.
Procto-Glyvenol in the form of suppositories should be used until the symptoms disappear.
If after 7 days of use there is no improvement or other, previously unobserved symptoms appear, consult a doctor to rule out other potential causes of these symptoms.
Page 2 of 5
No cases of overdose with Procto-Glyvenol in the form of suppositories have been reported. There is no specific antidote for lidocaine.
Overdose should not occur when using the medicine according to the recommended dosage regimen.
In case of overdose, consult a doctor immediately.
Do not use a double dose to make up for a missed dose.
In case of further doubts about the use of this medicine, consult a doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
To assess the side effects, the following frequency categories have been used:
Rare side effects(more than 1 person in 10,000, less than 1 person in 1,000):
Very rare side effects(may occur in up to 1 person in 10,000):
If any side effects occur, including any side effects not listed in the leaflet, the patient should inform their doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
By reporting side effects, more information can be collected on the safety of the medicine.
Page 3 of 5
Very common | occurs in more than 1 person in 10 |
Common | occurs in 1 to 10 people in 100 |
Uncommon | occurs in 1 to 10 people in 1,000 |
Rare | occurs in 1 to 10 people in 10,000 |
Very rare | occurs in less than 1 person in 10,000 |
Frequency not known | frequency cannot be estimated from the available data |
The medicine should be stored out of sight and reach of children.
Store in a temperature below 30°C, in the original packaging.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Procto-Glyvenol is available in the form of yellowish-white, cone-shaped suppositories, uniform, without cracks, slightly greasy, not soft.
Available packages:10 suppositories in PE-PP-Al foil blisters, in a cardboard box.
To obtain more detailed information, consult the marketing authorization holder or parallel importer.
Recordati România S.R.L.
Str. Izvor nr. 92-96
Biroul B, Camerele 2-8, Etaj 4, Sector 5
Bucharest, Romania
DELPHARM HUNINGUE SAS
26 rue de la Chapelle
68330 Huningue
France
ZETA FARMACEUTICI S.p.A.
Via Galvani, 10
36066 Sandrigo (VI)
Italy
Delfarma Sp. z o.o.
ul. Św. Teresy od Dzieciątka Jezus 111
91-222 Łódź
Delfarma Sp. z o.o.
ul. Św. Teresy od Dzieciątka Jezus 111
91-222 Łódź
Romanian export authorization number: 7351/2015/01
Page 4 of 5
[Information about the trademark]
Page 5 of 5
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.